ACADIA Pharmaceuticals
ACADIA Pharmaceuticals
Employees:
400
Market Cap:
$3.03 billion
Revenue:
$124.95 million
5 Year Trend:
91.0%
Net Income:
$-283.39 million
NASDAQ:
ACAD

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinsons disease psychosis. Wikipedia

ACADIA Pharmaceuticals

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company. The company has a portfolio of four product candidates, including pimavanserin, which is in Phase IV development as a treatment for Parkinsons disease psychosis. Wikipedia

Employees:
400
Market Cap:
$3.03 billion
Revenue:
$124.95 million
5 Year Trend:
91.0%
Net Income:
$-283.39 million
NASDAQ:
ACAD

16 jobs at ACADIA Pharmaceuticals

Jobs in